SCHEMBL28042364

SCHEMBL28042364

COc1c(Br)cc(NC(=O)O)cc1C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
TDP1 Q9NUW8 2/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TPMT P51580 1/20 0.40
TNFRSF1A P19438 1/20 0.38
MAPT P10636 3/20 0.38
HPGD P15428 2/20 0.38
ERBB2 P04626 2/20 0.37
EGFR P00533 1/20 0.37
NR1H4 Q96RI1 1/20 0.36
TSHR P16473 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
APOBEC3A P31941 1/20 0.36
HTT P42858 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL482536 0.88 ALDH1A1 (0.57) ALDH1A1TDP1GAAHSD17B10TPMT
SCHEMBL10978020 0.85 HPGD (0.49) ALDH1A1HSD17B10TPMTMAPTHPGD
SCHEMBL483090 0.84 ALDH1A1 (0.39) ALDH1A1TDP1GAAHSD17B10TPMT
SCHEMBL1530412 0.77 MAPT (0.37) ALDH1A1TDP1GAAHSD17B10TNFRSF1A
SCHEMBL1530410 0.77 MAPT (0.37) ALDH1A1TDP1GAAHSD17B10TNFRSF1A
SCHEMBL1627319 0.73 CA2 (0.43) ALDH1A1TDP1HSD17B10MAPTERBB2
SCHEMBL295404 0.73 ALDH1A1 (0.72) ALDH1A1TDP1GAATNFRSF1AMAPT
SCHEMBL18950804 0.73 ALDH1A1 (0.45) ALDH1A1TDP1GAA
SCHEMBL1530698 0.71 HSD17B10 (0.47) ALDH1A1TDP1HSD17B10TPMTTNFRSF1A
SCHEMBL5090250 0.71 CA2 (0.55) ALDH1A1TDP1GAAHSD17B10TPMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102448920-B Antiviral compounds and uses thereof ABBVIE (US) 2016-04-06 CN disclosed